In Asia, about 1%-19.1% of the population suffer from urolithiasis. However, due to variations in socio-economic status and geographic locations, the prevalence and incidence have changed in different countries or regions over the years. The research for risk factors of urinary tract stones is of predominant importance. In this review, we find the prevalence of…
Asian journal of urology Template
Write in a clean editor, then format for Asian journal of urology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Asian journal of urology format
Asian journal of urology is a peer-reviewed journal published by Elsevier, covering Prostate Cancer Diagnosis and Treatment, Kidney Stones and Urolithiasis Treatments, Prostate Cancer Treatment and Research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Asian journal of urology 12 (2023) 45–58.
Formats any DOI in Asian journal of urology style. No sign-up. |
| Publishes research in | Prostate Cancer Diagnosis and Treatment Kidney Stones and Urolithiasis Treatments Prostate Cancer Treatment and Research Urinary Bladder and Prostate Research Ureteral procedures and complications |
| ISSN | 2214-3882 |
| Citation impact (2-yr) | 1.7 |
| h-index | 43 |
| i10-index | 258 |
| Total citations | 9,725 |
| Open access | Yes |
| Top institutions publishing here | Second Military Medical University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Asian journal of urology per year
Citation impact of Asian journal of urology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Asian journal of urology
Clinical benign prostatic hyperplasia (BPH) is one of the most common diseases in ageing men and the most common cause of lower urinary tract symptoms (LUTS). The prevalence of BPH increases after the age of 40 years, with a prevalence of 8%-60% at age 90 years. Some data have suggested that there is decreased risk…
The incidence of prostate cancer (PCa) within Asian population used to be much lower than in the Western population; however, in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCa diagnosis, current status…
Benign prostatic hyperplasia (BPH) is a benign enlargement of the prostate in which incidence increases linearly with age, beginning at about 50 years old. BPH is a significant source of morbidity in aging men by causing lower urinary tract symptoms and acute urinary retention. Unfortunately, the etiology of BPH incidence and progression is not clear.…
Diagnosis of prostate cancer (PCa) and adequate staging play a fundamental role for clinical and patient care. Despite major advances in biology and imaging, rectal examination and prostate-specific antigen (PSA) blood test remain the cornerstone for screening, and multiparametricmagnetic resonance imaging (mpMRI) for local staging. Recent advances in mpMRI lead to standardised interpretation and increased…